Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

Overview of attention for article published in Investigational New Drugs, February 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#27 of 1,197)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet

patent: 25 patents

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 25 patents that reference this research output.

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

About this Attention Score

Mentioned by

Citations

Readers on

Method of treating cancer associated with a RAS mutation

Grant US-11918574-B2

United States of America

METHODS AND COMPOSITIONS FOR TREATING IRON DISORDERS

Application EP-4045046-A4

European Patent Office

Compositions containing tucaresol or its analogs

Grant US-11857522-B2

United States of America

Composition and method for reducing thrombocytopenia

Grant US-11786523-B2

United States of America

Tubulin binding compounds and therapeutic use thereof

Grant US-11633393-B2

United States of America

Polycrystalline form of dehydrophenylahistin-like compound, and manufacturing and…

Grant US-11608325-B2

United States of America

Polycrystalline form of dehydrophenylahistin-like compound, and manufacturing and…

Grant US-11578057-B2

United States of America

Method of reducing chemotherapy-induced neutropenia

Grant US-11400086-B2

United States of America

Plinabulin compositions

Grant US-11254657-B2

United States of America

Composition and method for reducing neutropenia

Grant US-11229642-B2

United States of America

METHOD FOR REDUCING NEUTROPENIA

Application RU-2760348-C2

Russian Federation

Method of treating cancer associated with a RAS mutation

Grant US-11045467-B2

United States of America

Compositions containing tucaresol or its analogs

Grant US-10912748-B2

United States of America

METHOD OF REDUCING NEUTROPENIA

Application EP-3576733-A4

European Patent Office

CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE

Application US-20200281921-A1

United States of America

Method of treating cancer associated with a RAS mutation

Grant US-10668063-B2

United States of America

Cancer treatment with combination of plinabulin and taxane

Grant US-10596169-B2

United States of America

Cancer treatment with combination of plinabulin and taxane

Grant AU-2013402794-B2

Australia

Plinabulin compositions

Grant US-10550104-B2

United States of America

Method of treating a brain tumor

Grant US-10357491-B2

United States of America

Plinabulin compositions

Grant US-10155748-B2

United States of America

Method of treating a brain tumor

Grant US-10076518-B2

United States of America

TREATMENT OF CANCER BY COMBINATION OF PLINABULIN AND TAXANE

Application RU-2662298-C2

Russian Federation

Combination cancer treatment of plinabulin and taxane

Application JP-2016536352-A

Japan

CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE

Application WO-2015051543-A1

World Intellectual Property Organisation (WIPO)